✦ LIBER ✦

The GLP-1 analogue, LY307161, potently lowers post prandial blood glucose in subjects with type 2 diabetes

✍ Scribed by StevenJ. Pascoe; Christopher Payne; Michael Trautmann

Book ID: 117369696
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 108 KB
Volume: 50
Category: Article
ISSN: 0168-8227
DOI: 10.1016/s0168-8227(00)81597-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of carbohydrate source on post-pr

Effect of carbohydrate source on post-prandial blood glucose in subjects with type 1 diabetes treated with insulin lispro

✍ Nadia H Mohammed; Thomas M.S Wolever 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 84 KB

The effect of improved post-prandial blo

The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes

✍ A. Gallagher; P.D. Home 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Effects of liraglutide (NN2211), a long-

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes

✍ M. N. Feinglos; M. F. Saad; F. X. Pi-Sunyer; B. An; O. Santiago; on behalf of th 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Near normalisation of blood glucose impr

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

✍ P. V. Højberg; M. Zander; T. Vilsbøll; F. K. Knop; T. Krarup; A. Vølund; J. J. H 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 227 KB

Reductions in Post-Prandial Glucagon by

Reductions in Post-Prandial Glucagon by the GLP-1 Receptor Agonist Lixisenatide Correlate to Reductions in PPG and A1C in Patients with Type 2 Diabetes Mellitus

✍ Aronson, Ronnie; Galstyan, Gagik; Gautier, Jean-Francois; Giorgino, Francesco; G 📂 Article 📅 2014 🏛 Canadian Diabetes Association 🌐 English ⚖ 233 KB

A novel GLP-1 analog exhibits potent uti

A novel GLP-1 analog exhibits potent utility in the treatment of type 2 diabetes with an extended half-life and efficient glucose clearance in vivo

✍ Ying Li; Weiren Xu; Lida Tang; Min Gong; Jianning Zhang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB